| Day & time | 23 OCT 2008 |
|---|---|
| 09:00 09:10 |
Opening Renato D. Lopes and Richard C. Becker |
| President Eulógio Martinez |
|
| 09:10 09:30 |
Importance of thrombosis and anticoagulation in clinical
practice Richard C. Becker |
| 09:40 10:00 |
Endothelium - What is the role in thrombosis? Protasio Lemos da Luz |
| 10:10 10:30 |
Pathways of coagulation Dayse Lourenço |
| 10:30 10:50 |
Coffee Break |
| 10:50 11:10 |
Pharmacokinetics and pharmocodynamics of heparin
Helena B. Nader |
| 11:20 11:40 |
Pharmacokinetics and pharmocodynamics of Vitamin
K antagonists Francisco H. Maffei |
| 11:40 12:00 |
Questions |
| 12:00 14:00 |
Break |
| President Christopher B. Granger |
|
| 14:00 |
Anticoagulation in acute coronary syndrome with ST-segment
elevation José Carlos Nicolau |
| 14:50 |
Anticoagulation in acute coronary syndrome without ST-segment
elevation Ari Timerman |
| 15:00 15:20 |
Atrial fibrillation and Acute coronary syndrome |
| 15:50 |
Stroke prevention in patients with atrial fibrillation
|
| 15:50 16:30 |
Coffee Break |
| 16:30 17:00 |
Atrial fibrillation: What did we learn from the trials?
|
| 17:10 17:40 |
Case Chris Granger and Antonio Carlos Chagas |
| Day & time | 24 OCT 2008 |
| President Francisco H. Maffei |
|
| 09:00 09:20 |
Improve and Endorse – Epidemiology study Ana Rocha |
| 09:25 09:55 |
Brazilian Guidelines for venous thromboembolism prophylaxis
in medical patients |
| 10:00 10:20 |
From theory to practice – Safety Zone program Edison Paiva |
| 10:20 10:40 |
Coffee Break |
| 10:40 11:10 |
Optimal Duration of therapy for VTE David Garcia |
| 11:15 11:45 |
Prevail and Exclaim Study Ana Rocha |
| 11:50 12:10 |
Orthopedics surgery – How to prevent thromboembolic events?
Hélio Penna Guimarães |
| 12:15 12:45 |
Case Richard C. Becker |
| 12:45 14:00 |
Break |
| President Richard C. Becker |
|
| 14:00 14:40 |
Bridging (Perioperative) anticoagulation – Risks and Benefits David Garcia |
| 14:50 15:10 |
Valve disease: when and how to do the anticoagulation?
Antonio Carlos Carvalho |
| 15:20 15:50 |
Predicting bleeding risk for patients contemplating warfarin
- Where do we stand now? Elaine Hylek |
| 16:00 16:20 |
Coffee Break |
| 16:20 16:50 |
New anticoagulants in development Christopher Granger |
| 17:00 17:30 |
Case David Garcia and Renato D. Lopes |
| Day & time | 25 OCT 2008 |
| President Miguel Cendoroglo |
|
| 09:00 09:20 |
When and how to do the anticoagulation in patients with
cancer? Elbio Damico |
| 09:30 10:00 |
Hormone therapy versus thrombosis – Where do we stand
in 2008? José Mendes Aldrighi |
| 10:10 10:40 |
How to diagnose and treat heparin induced thrombocytopenia?
Richard C. Becker |
| 10:40 11:00 |
Coffee Break |
| 11:00 11:30 |
Future directions: pharmacogenomics Carlos A. Moreira Jr. |
| 11:40 12:00 |
Questions and closing remarks Richard C. Becker and Renato D. Lopes |